Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$916K Sell
57,696
-583
-1% -$9.04K 0.25% 36
2026
Q1
$787K Hold
58,279
0.23% 36
2025
Q4
$726K Hold
58,279
0.23% 34
2025
Q3
$577K Hold
58,279
0.18% 38
2025
Q2
$520K Hold
58,279
0.17% 37
2025
Q1
$508K Hold
58,279
0.16% 36
2024
Q4
$726K Sell
58,279
-554
-0.9% -$6.81K 0.23% 34
2024
Q3
$683K Hold
58,833
0.2% 35
2024
Q2
$625K Buy
58,833
+581
+1% +$6.42K 0.21% 35
2024
Q1
$696K Hold
58,252
0.23% 33
2023
Q4
$631K Hold
58,252
0.22% 31
2023
Q3
$581K Sell
58,252
-1,287
-2% -$13.4K 0.2% 32
2023
Q2
$594K Hold
59,539
0.17% 32
2023
Q1
$573K Sell
59,539
-733
-1% -$8.13K 0.16% 33
2022
Q4
$671K Sell
60,272
-1,240
-2% -$13K 0.17% 30
2022
Q3
$524K Hold
61,512
0.14% 33
2022
Q2
$644K Hold
61,512
0.15% 31
2022
Q1
$669K Hold
61,512
0.14% 30
2021
Q4
$832K Hold
61,512
0.17% 28
2021
Q3
$833K Buy
+61,512
New +$873K 0.18% 29

Other funds holding VTRS

Bruce & Co's VTRS Position: Q2 2026 in Review

Bruce & Co reduced its Viatris (VTRS) stake by 1% in Q2 2026, selling an estimated $9.04K and leaving 57,696 shares worth $916K. The position accounts for 0.25% of the portfolio, ranked #36.

Bruce & Co first reported a position in VTRS in Q3 2021 and has held it in 20 quarters since. 1,028 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Bruce & Co held 57,696 shares of Viatris worth $916K as of Q2 2026.
  • Bruce & Co sold 583 Viatris shares in Q2 2026, an estimated $9.04K.
  • Viatris made up 0.25% of Bruce & Co's portfolio in Q2 2026, its #36 holding.
  • Bruce & Co first reported a position in Viatris in Q3 2021 and has held it in 20 quarters since.
  • 1,028 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Bruce & Co's 13F filing for Q2 2026, filed 14 Aug 2026.